Introduction:
Crizalk 250mg Capsules contain the active ingredient crizotinib. It is prescribed to treat patients who have been diagnosed with a lung cancer called non-small cell lung cancer (NSCLC). This drug is active against altered forms of the ALK protein when the patient does not respond to other anticancer treatments.
Tell your doctor about any symptoms such as yellowing of the skin, dark urine, nausea, vomiting, loss of appetite, pain in the right side of the abdomen, bleeding and bruising.
Uses of Crizalk 250mg Capsule:
Treatment of advanced lung cancer (NSCLC) that has spread to other organs.
How Crizalk 250mg Capsule works: Mutations or changes in the ALK protein play an essential role in the progression of tumor cells. ALK-positive refers to cancer cells that contain errors in the gene responsible for making the ALK enzyme. Crizalk 250mg Capsule inhibits the anaplastic lymphoma kinase (ALK) enzyme and stops the tumor growth.
Interactions with other drugs:
Before treatment, tell your doctor about all medicines you are taking or are taking.
More information:
Store at room temperature (15-30˚C) in the original container.
For other medicines and pharmaceutical help checkout MrMed.
Comments